Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

132 new *Nigeria

12th World AIDS Conference

requently found among
subtypes (clades) by a
V vaccine candidates/A
CD38/8 Evaluation of a
FV) in combination with
d with progression to a
/Similar risk factors for
e: Changing trends and
oland: Paradigm for the
ological background for
/Characteristics of the
and youths attending a
nt of STDs in Ghana - A
y/Kaposi's sarcoma: A
ons: Implementation of
AIDS in Italy: The role of
V infection/Effect of the
sistance/Impact of the
d risk behaviors among
I perspective/Toward a
ctice after 18 months of
thanasia: old problems,
iving with HIV/AIDS - A
hers and children/The
petency in AIDS work; A
ed diarrhea/SP-303: A
e to therapy/Towards a
uction cards system: A
gies/Consequences of
Tanzania/Outlining of a
HIV/AIDS messages/A
among young people/A
orkers in Lima, Peru/A
s gay men in the era of
ge and attitudes about
PLWHA)/Adapting to!/Attitudes towards the
aptation of services to a
n of HIV-1 subtypes by a
AIDS/Identification of a
un-Tests~ HIV combi/A
d percentage values/A
parative evaluation of a
HIV-1 monitor test with
cacy of PNU-140690, a
bitor of HIV-1/S-1153, a
effects of interferon-r, a
ainst both wild-type and
munodeficiency virus/A
ded HIV antigens/The
HIV-primary infection/A
D45 activity in T cells: A
ping/Development of a
efficacy and safety of a
nfirms effectiveness of
ment: Consequence of
Zambian experience/A
gay men/The impact of
dent-driven sampling: a
n Belgium in the era of
em/An old method for a
anisation/Impact of the
aws (HULs)/Fighting a"
al uncertainty related to
rce/The implications of
e guidelines/Designing
and seroconversion/A
ultiple herbal therapy: A
e F-5~ gel, a potentially
ethionine enkephalin: a
with HIV and AIDS?/Do
STD Epi Fact Sheets: a
load/Usefulness of the
TA - Development of a

tection in the course of
ntigen/Evaluation of a
gnant women and their r
d anonymous testing of r
natal HIV-1 infection in
roup - A success story/ I

S Keyword Abstract - Keyword Abstract -
full length sequences/Inter-subtype r 435*/11170 through publication of a newsletter /Grassroot community mobilis 33480
virus-binding assay/Mapping conserv 11178 rs in the life of a PLWHA /Ten years in the life of a PLWH 60939
pathogenic SHIV-cynomolgus monke 11228 ealth networks through newsletters /Promoting sexual health net 33510
subrogate marker/CD38/8 Evaluation 12140 n a NGO and a national newspaper: A successful experience of co 586*/34219
nucleoside analogs in nucleoside exp 125*/12203 s is modulated through NF-KB /TNF-a production by alveolar macr 21179
AIDS defining event or death in patien 12282 c efficacy of nelfinavir ( NFV ) and/or efavirenz (EFV) in combinatio 125*/12203
infection with HIV-1 subtypes B' and E 13144 V-SGC) plus nelfinavir ( ) in HIV-infected individuals/Study of p 290*/12222
challenges/The HIV/AIDS epidemic i 522*/13179 SQV-SGC) + nelfinavir ( ) + nucleoside reverse transcriptase in 12248
AIDS frontier/Possible epidemic spre 13186 udine (d4T), nelfinavir ( ) and nevirapine (NVP): Suppression 12275
prevention strategies among youths a 13392 cleosides or nelfinavir ( ) plus 1 nucleoside in HIV-1 infected p 12314
cases of tuberculosis (TB) after the im 22155 KC-442 and nelfinavir ( ) in healthy male and female volunteer 12380
special STD clinic for them in Dar es S 22203 ment (TX) of nelfinavir ( ) induced diarrhea (NFVID)/The treat 12383
dimension/Syndromic management o 22204 lerability of nelfinavir ( ) in combination with efavirenz (EFV, 22386
approach to follow-up using epilumine 22286 f d4T + 3TC + SQV + with or without interleukin-2 in early HI 22414
guidelines for treatment of HIV infectio 22333 navir (RTV), nelfinavir ( ), and the nelfinavir active metabolite 42265
combination antiretroviral therapies/I 22367 s of nelfinavir mesylate (;Viracept~) in HIV-infected children/S 42274
antiviral therapy in the quality of life, p 22392 avir (IDV) to nelfinavir ( )in patients on antiviral combination th 60181
antiviral therapies in persons with AID 22445 NFV) induced diarrhea ( NFVID )/The treatment (TX) of nelfinavir (N 12383
initiates into injection drug use over 40 23176 ment and maintenance/ NGC 891: Multidrug regime in HIV infection 60044
paradigm for HIV prevention: An ecop 23375 AIDS programs through NGO-to-NGO exchange visits/Enhancing 34352
antiviral therapy: The Parisian experie 24154 ence of a South African NGO initiative/Community-based home-b 12427
issues/AIDS and euthanasia: old pro 43*/24244 TDs prevention work by in prison settings in St. Petersburg re 33203
concept for group programs/Living wit 24261 dia through judicial and activism/Blood safety in India throug 33205
underground railroad: Bridging the ga 24293 inics in Bangalore - An 's experience in the Indian context/Es 33260
paradigm/Competency in AIDS work; 24313 rience of an AIDS Care in the C6te d'lvoire/Attitudes of PWA 33300
treatment for AIDS-associated diarrhe 32106 oration with an national for handicapped people/STOP AIDS 33462
approach for the assessment of adher 32382 atments in Asia through collaborations/Investigations of acce 34104
way to provide information to injecting 33418 atments in Asia through collaborations/Investigation of acces 199*/34141
orientations in treatments for preventi 33458 us/Creation of the first working in the AIDS field ten years aft 34183
IEC strategy for Tanzania/Outlining of 33471 /agreement between a and a national newspaper: A success 586*/34219
UNAIDS framework for communicatin 33487 boration between AIDS and mass media in AIDS education e 34224
tool for intervention/awareness amon 33496 mprove the service of an /Using quality standards to improve t 34324
system monitoring and evaluation in a 33595 s in the Amazon region/ 's network/working together to reduce 34359
treatments: A comparison of two natio 642*/34107 ears' experience by an in the C6te d'lvoire/HIV/AIDS care a 42413
HIV drug treatments among NYC Lati 34116 o improve the quality of prevention programmes in Asia/Usin 43157
challenges: A joint process of integrati 34162 /Partnership between and GO - The experience of the Stat 43201
triple-therapies and safer sex: What a 34277 ho were attended in an in Rosario, 1995-1997/Prevalence o 43466
treatments climate by a UK ASO/Ada 34322 ns: Lessons learned by AIDS Cell/Multiplicity of small interve 44295
rapid immunochromatographic test/D 41107 V and AIDS patients at,OPD clinic, Bangalore, India/Out pat 60054
virus-associated epitope inducing anti 41111 pment for intervention/ - Networking at national level and str 60101
generation of HIV-diagnostic assay: R 41113 pport/Experience of an (ASO) on orphans support/Experien 60838
approach to flow cytometry based CD 41116 ears on the activities of worked with HIV/AIDS in Fukuoka, Ja 60851
test for HIV-RNA quantitation in plasm 41132 be news strategies for NGOS to helps women and youth to have a 14202
gag primers, and a prototype automat 41145 ching a network of AIDS in Russia/Launching a network of A 34341
non-peptidic HIV protease inhibitor, in 293*/41176 S NGOs network: AIDS Network in East Africa (ANNEA) ex 34353
nonnucleoside reverse transcriptase i 553*/41181 cation for youth groups/ /Peer education for youth groups/ 60763
type I interferon/Anti-HIV and immun 41186 and capacity building of NGOs for effective intervention process/N 13494
analogs of HIV-1 protease/A resistan 555*/41212 ising research tools for and health departments/Incorporati 14154
approach for developing a selectable I 41251 o society/PLWHA-LED too need compassion and support f 33378
Cobas Core Anti-HIV-1/2 EIA DAGS II 42108 trategic planning with responding to HIV/AIDS in India/Fa 34149
generation test associating antigen an 42126 e between UK ASO and in India, Caribbean, Romania, Ukrai 34331
surrogate marker of HIV disease/CD4 42183 e/Establishing an AIDS network: AIDS NGOS Network in E 34353
DNA-array based GeneChip~ assay f 42196 lopment to answer the and the public sector needs on HIV/ 43225
poly herbal drug in the management o 42394 dvocacy: A Kenya AIDS consortium initiative/HIV/AIDS poli 43566
therapies/HAART in clinical practice: 42437 or developing country through external relations capacity 44263
antiviral strategies/Changing patterns 42440 ging the gap: US-based and ASOs and the global epidemic/ 44273
approach to involving the community i 43198 aluation of Kenya AIDS Consortium (KANCO) Resource Ce 60218
combination HIV therapies on knowle 43260 port on AIDS activity for in Thailand in 1995/Financial suppo 60600
approach to sampling hidden populati 43420 FOSI", AIDS forum of in Democratic Republic of Congo/S 60720
treatments/Monitoring the HIV/AIDS 43450 ce: "Thanks to God Joly Ngoya is still alive"/Life experience: "Than 60725
problem/An old method for a 43533 kin's lymphoma (AIDS- NHL ) patients: Pilot study/Idarubicin conta 22294
trends of epidemic of AIDS on AP-HP, 43565 -Hodgkin's lymphoma ( )/Risk factors for AIDS associated no 22295
" virus: Highly useless laws (HULs)/Fi 44114 ) haemophilia patients/ - 17 years follow-up in a Greek cohort 22298
antiretroviral therapies/Ethical implic 44129 phoma patients (AIDS- pts)/Effect on virological and immuno 60487
treatments on PLWHA who work or ar 44189 -Hodgkin's lymphoma ( ) in Lagos, Nigeria/Prevalence study 60581
STD surveillance guidelines/Designin 60120 prevalency evolution in Niamey, Niger/HIV-2 infection seropreval 60094
combined HIV antigen/antibody scree 60167 he Caribbean Coast of Nicaragua, 1991-1997/AIDS related kno 14280
approach into antiviral treatment, 1. In 60205 A cluster analysis of the NIDA AIDS outreach cooperative agreeme 14276
vaginal microbicide for STD preventio 60370 es in the Tenere desert, Niger /HIV-1 seropositity among prostitute 43564
cytokine inhibits HIV replication in PB 60525 ncy evolution in Niamey, /HIV-2 infection seroprevalency evol 60094
medications change coping with HIV a 60609 syndrome in Benin City, Nigeria /Clinico-epidemiological features o 13177
tool for surveillance in Latin America a 60641 rison inmates in Lagos, /Initial drug resistance tuberculosi 13255
NASBA ultrasensitive assay (Nuclise 60679 rison inmates in Lagos, /Pulmonary tuberculosis and HIV i 13256

concept for secondary and tertiary pre 60718 HIV/AIDS in Benin City, (January 1994 to April 1997)/Adol 13399
sexual encounters: A general populati 60733 t/Christian hospitals in provide integrated post-absortion 13474
automated screening test for the simul 60945 ool students in Ibadan,: A review of effectiveness/A scho 13558
lewborn in Moscow, Russia/Care of HIV+ 60530 rkers in Enugu State of /A survey of knowledge, attitude, b 14132
iewborns 1993-1997/Monitoring of HIV- 13187 tients with HIV/AIDS in /Improving the capacity of nurses t 22468
delivered within one hour of rup 23305 CSWs) in Borno State, /Impact of HIV/AIDS enlightenmen 23344
Nlewham women's group - A success stor 44265 STDs in rural schools in /Knowledge, attitude and practice r 23433